Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information


vanessa.raymont@psych.ox.ac.uk


+44 (0)1865 613147

Vanessa Raymont

MBChB MSc MRCPsych

Senior Clinical Researcher, R&D Director Oxford Health NHS Foundation Trust

  • Honorary Senior Clinical Research Fellow, Centre of Dementia Prevention, University of Edinburgh
  • Honorary Consultant Psychiatrist

My clinical and research interests are in traumatic brain injury, and memory disorders and dementia, as well as clinical trials in cognitive impairment, having worked for over 20 years in clinical trials in the UK and US. 

I am currently the Principal Investigator for the New Therapeutics in Alzheimer’s Disease (NTAD), Brains for Dementia Research (BDR) and 7Tesla MRI Scanning in Alzheimer’s disease and Frontotemporal Lobar Degeneration studies and Chief Investigator on the  Deep and Frequent Phenotyping (DFP) study and a NHIR-funded study assessing the use of sertraline to prevent post-head injury depression. I am co-lead for the Clinical Trials section of Oxford Translational Neuroscience and Dementia Research Group and NIHR Dementia and Mental Health Lead for the Thames Valley and South Midlands Clinical Research Network. I am an associate director of Dementia Platforms UK, and workstream lead for the Trials Delivery Framework. I serve as a Commissioner for the Commission on Human Medicines.

Recent publications